Atlas Trials

Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia

Clinical trial NCT07471516 · RECRUITING

Trial details

NCT number
NCT07471516
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Congenital Dyserythropoietic Anemia (CDA)
Start date
2026-02-25
Primary completion
2027-02-25
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.